Solvay Pharmaceuticals
European Neurological Review Supplement

Welcome to this supplement to our European Neurological Review journal, which focuses on cutting edge work in the field of advanced Parkinson's disease. Based on a one-day symposium organised by Solvay Pharmaceuticals, this supplement contains papers written by the eight distinguished speakers at the symposium that discuss the latest research and sophisticated clinical practice. Topics covered include involving the patient in their own treatment, the economic burden of Parkinson’s disease, the effects of continuous dopaminergic stimulation and issues concerning quality of life. If you would like to receive a hard copy of this publication, please click here.

Papers include:

Challenges in the Long-term Evolution
of Parkinson’s Disease
José Obeso

Illustrations of Physiotherapy
Intervention in Parkinson’s Disease
Mariella Graziano

STN-DBS – Quality of Life and
Influence of Ageing
Patricia Limousin

Continuous Dopaminergic Stimulation
in Spanish Patients with Late
Parkinson’s Disease
Francesc Valldeoriola

The Therapeutic Place of Duodopa
Jens Volkmann